Target intelligence / Profile preview

Direct Viral-Mediated Tumor Cell Lysis

Molecular classification
Viral Replication, Cell Death, Immunogenic Cell Death
01

Overview

Direct viral-mediated tumor cell lysis refers to the process by which oncolytic viruses selectively infect and destroy cancer cells through their replication cycle, leading to the physical rupture (lysis) of tumor cells. This mechanism is a cornerstone of oncolytic virotherapy, a form of cancer treatment that exploits viruses' natural or engineered ability to target and kill malignant cells while sparing normal tissue.

02

Mechanism of action

Oncolytic viruses selectively infect and destroy cancer cells through their replication cycle, leading to the physical rupture (lysis) of tumor cells. This releases new virions and tumor-associated antigens, triggering an immune response.

03

Biological functions

Tumor Cell DestructionViral ReplicationRelease of Tumor-Associated AntigensActivation of Immune Response
04

Disease associations

Cancer
05

Safety considerations

Off-target effects on normal cellsPotential for uncontrolled viral replicationImmune response against the virusPre-existing immunity to the virusInsertional mutagenesis (for integrating viruses)
06

Interacting drugs

Oncolytic Viruses (e.g., Herpes simplex virus (HSV), Vaccinia virus, Vesicular stomatitis virus (VSV), Reovirus)
07

Biomarkers

Tumor-associated antigens (TAAs)Damage-associated molecular patterns (DAMPs)Pathogen-associated molecular patterns (PAMPs)Viral load within tumor

Beyond the preview

Go deeper on Direct Viral-Mediated Tumor Cell Lysis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Direct Viral-Mediated Tumor Cell Lysis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call